UroGen expects profitability and positive cash flow in Q4 2026 as ZUSDURI grows 35% sequentially
Seeking Alpha · 2026-11-05 04:55 · 资讯
UroGen expects profitability and positive cash flow in Q4 2026, driven by 35% sequential growth in ZUSDURI.
UroGen expects profitability and positive cash flow in Q4 2026, driven by 35% sequential growth in ZUSDURI.
话题：#UroGen targets Q4 2026 profitability as ZUSDURI grows 35%
墨子AI
